Semaglutide

Service Description

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that acts like the GLP-1 hormone released in the digestive tract when eating. The medication is available by prescription only and is used as a weekly injection to help with blood sugar management and help reduce the risk of a heart attack or stroke in people with type 2 diabetes. Semaglutide has shown effectiveness in reducing body weight for those with overweight or obesity.